About

Alexandra Ritter is Head of Regulatory Affairs and Combination Products at Aptar Pharma. In her role, she is responsible for ensuring that Aptar Pharma’s products meet the strict regulations and guidelines set by the relevant authorities and regulatory bodies, as well providing regulatory support to Aptar Pharma’s pharmaceutical and medical device customers. With more than 20 years’ experience in regulatory affairs for pharmaceutical products, prior to joining Aptar Pharma in 2014, Mrs Ritter held various regulatory positions at a global pharmaceutical company.

Contributions

OCULAR

AN EYE ON THE FUTURE OF PRESERVATIVE-FREE DROPS

Alexandra Ritter and Matthias Birkhoff discuss the importance of the regulatory support the company offers to its customers for preservative-free ophthalmic platforms in the face of increasingly stringent regulatory requirements from both the EU EMA and US FDA, and describe new opportunities and growing demand for a wider range of multidose preservative-free ophthalmic drug-device combinations, including for indications such as dry-eye and glaucoma.